- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PBT and atezolizumab/bevacizumab
Total 6968 results
-
McGill University Health Centre/Research Institute...Unknown
-
Beijing Syngentech Co., Ltd.Not yet recruitingHepatocellular Carcinoma
-
Bavarian NordicCompletedBladder CancerUnited States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Italy, Netherlands
-
University of Michigan Rogel Cancer CenterTerminated
-
Niharika MettuRoche-GenentechWithdrawnMetastatic Colorectal CancerUnited States
-
Coherus Biosciences, Inc.Active, not recruitingHepatocellular CarcinomaUnited States, Taiwan, Korea, Republic of, Australia
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, United Kingdom, Belgium, Netherlands
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Institut CurieRoche Pharma AG; Replimune Inc.Not yet recruitingTriple Negative Breast NeoplasmsFrance
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
Hoffmann-La RocheCompletedColorectal CancerCanada, United States, Italy, Korea, Republic of, United Kingdom, Belgium, Russian Federation, Hong Kong, Spain, Australia, Poland
-
University Hospital Southampton NHS Foundation...Roche Pharma AG; Cancer Research UKRecruitingSquamous Cell Carcinoma | Urinary Tract CancerUnited Kingdom
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
National Cancer Institute (NCI)CompletedPineoblastoma | Recurrent Medulloblastoma | Refractory Medulloblastoma | Refractory Peripheral Primitive Neuroectodermal Tumor | Central Nervous System Neoplasm | Recurrent Primitive Neuroectodermal TumorUnited States, Canada, Puerto Rico, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
PfizerRecruitingNon-Small Cell Lung CancerNorway
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Korea, Republic of, United Kingdom, Canada, China, Hong Kong, Taiwan, Australia, Italy, Spain, Czechia, Japan, Singapore, France, Germany, Poland, Russian Federation
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild TypeUnited States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
Chugai PharmaceuticalRecruitingHepatocellular Carcinoma (HCC)Taiwan, Japan
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Keythera Pharmaceuticals (Australia) Pty LtdRecruitingGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
National Cancer Institute (NCI)NRG OncologyRecruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v7United States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v6United States, Puerto Rico
-
I-Mab Biopharma US LimitedNo longer availableCancerUnited States
-
The Netherlands Cancer InstituteRoche Pharma AGTerminatedBreast CancerNetherlands
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Hoffmann-La RocheWithdrawn
-
Darell BignerGenentech, Inc.; Istari Oncology, Inc.Withdrawn
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IV Hypopharyngeal... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Advanced Sarcomatoid Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States, Korea, Republic of, Canada
-
National Cancer Institute (NCI)Active, not recruitingCombined Hepatocellular Carcinoma and Cholangiocarcinoma | Stage III Liver Cancer | Stage IV Liver CancerUnited States
-
Institute of Cancer Research, United KingdomHoffmann-La RocheRecruitingSolid Tumor | Glioblastoma Multiforme | Prostate Cancer MetastaticUnited Kingdom
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Ovarian Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage... and other conditionsUnited States
-
University of UtahCompletedCancer | Non Small Cell Lung CancerUnited States
-
University of Alabama at BirminghamWithdrawnMetastatic Colon CancerUnited States
-
Base Therapeutics (Shanghai) Co., Ltd.The General Hospital of Eastern Theater CommandRecruiting
-
University Medical Center GroningenMartini Hospital GroningenCompleted
-
University of Texas Southwestern Medical CenterGenentech, Inc.RecruitingColorectal CancerUnited States
-
Hoffmann-La RocheCompletedBiliary Tract CancerUnited States, Korea, Republic of, United Kingdom, Hong Kong, Spain, Italy, Turkey, China, Taiwan, Russian Federation, Poland, Thailand, Ukraine